← Leaderboards
Lijuan Yuan
University Of Maryland Baltimore
$3,888,254
Attributed
$5,881,378
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $647.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,881,378 · 5
By mechanism
R01$4,630,383 · 2
R21$1,250,995 · 3
Top collaborators
- Hanping Feng5 shared
- Kiho Lee2 shared
- Ming Tan1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Hanping Feng$19,880,798
- Meagan Colleen Fitzpatrick$649,319
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesFamily SuidaeDiarrheaGnotobioticMediatingInfectionGenomePreventIntestinesMorbidity - Disease RateOralProbioticsViralGastroenteritisEnteralDoseSiteProductionNorovirusAcuteIn VitroGenesFutureHospitalization
Grant awards (14)
A VP4-Based Pseudovirus Nanoparticle Rotavirus Vaccine for Oral Immunization$458,250
R21 · FY2025 · AI
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies$621,331
R01 · FY2024 · AI
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies$611,307
R01 · FY2023 · AI
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies$608,573
R01 · FY2022 · AI
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies$600,213
R01 · FY2021 · AI
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies$647,849
R01 · FY2020 · AI
CRISPR/Cas9 guided production of genetically engineered pigs lacking CD8+ T-cells$241,500
R21 · FY2016 · OD
CRISPR/Cas9 guided production of genetically engineered pigs lacking CD8+ T-cells$197,225
R21 · FY2015 · OD
Mechanisms of Immune Modulation by Probiotics$381,570
R01 · FY2012 · AT · contact PI
Mechanisms of Immune Modulation by Probiotics$382,131
R01 · FY2011 · AT · contact PI
Mechanisms of Immune Modulation by Probiotics$386,511
R01 · FY2010 · AT · contact PI
Mechanisms of Immune Modulation by Probiotics$390,898
R01 · FY2009 · AT · contact PI
Effects of Probiotic Lactobacilli on Rotavirus Immunity$176,540
R21 · FY2006 · AT · contact PI
Effects of Probiotic Lactobacilli on Rotavirus Immunity$177,480
R21 · FY2005 · AT